HABA Laboratories,Inc. (TYO:4925)
Japan · Delayed Price · Currency is JPY 1,715.00
-12.00 (-0.69%)
At close: Jan 23, 2026
HABA Laboratories,Inc. Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 12,156 | 12,061 | 12,324 | 12,038 | 12,908 | 14,307 | Upgrade | |
Revenue Growth (YoY) | -0.78% | -2.13% | 2.38% | -6.74% | -9.78% | -22.11% | Upgrade |
Cost of Revenue | 4,022 | 3,969 | 3,920 | 3,869 | 4,114 | 4,108 | Upgrade |
Gross Profit | 8,134 | 8,092 | 8,404 | 8,169 | 8,794 | 10,199 | Upgrade |
Selling, General & Admin | 7,153 | 7,405 | 8,214 | 8,427 | 8,650 | 9,464 | Upgrade |
Operating Expenses | 7,254 | 7,503 | 8,591 | 8,778 | 9,111 | 9,972 | Upgrade |
Operating Income | 880 | 589 | -187 | -609 | -317 | 227 | Upgrade |
Interest Expense | -18 | -17 | -9 | -6 | -7 | -7 | Upgrade |
Other Non Operating Income (Expenses) | 18 | 36 | 4 | 33 | 31 | 30 | Upgrade |
EBT Excluding Unusual Items | 880 | 608 | -192 | -582 | -293 | 250 | Upgrade |
Gain (Loss) on Sale of Investments | 7 | 7 | - | 6 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -3 | 9 | 1 | 25 | Upgrade |
Asset Writedown | - | - | -1,647 | -3 | -54 | -3 | Upgrade |
Other Unusual Items | 1 | 20 | -1 | 22 | 79 | 11 | Upgrade |
Pretax Income | 888 | 635 | -1,843 | -548 | -267 | 283 | Upgrade |
Income Tax Expense | 110 | 59 | 275 | 159 | 2 | 67 | Upgrade |
Net Income | 778 | 576 | -2,118 | -707 | -269 | 216 | Upgrade |
Net Income to Common | 778 | 576 | -2,118 | -707 | -269 | 216 | Upgrade |
Net Income Growth | - | - | - | - | - | -83.55% | Upgrade |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Change (YoY) | -0.00% | - | - | -0.00% | -0.00% | -2.30% | Upgrade |
EPS (Basic) | 205.74 | 152.32 | -560.09 | -186.96 | -71.13 | 57.12 | Upgrade |
EPS (Diluted) | 205.74 | 152.32 | -560.09 | -186.96 | -71.13 | 57.12 | Upgrade |
EPS Growth | - | - | - | - | - | -83.16% | Upgrade |
Free Cash Flow | 1,406 | 1,483 | -741 | -136 | 1,590 | -262 | Upgrade |
Free Cash Flow Per Share | 371.81 | 392.17 | -195.95 | -35.96 | 420.46 | -69.28 | Upgrade |
Dividend Per Share | 40.000 | 40.000 | 40.000 | 40.000 | 40.000 | 40.000 | Upgrade |
Gross Margin | 66.91% | 67.09% | 68.19% | 67.86% | 68.13% | 71.29% | Upgrade |
Operating Margin | 7.24% | 4.88% | -1.52% | -5.06% | -2.46% | 1.59% | Upgrade |
Profit Margin | 6.40% | 4.78% | -17.19% | -5.87% | -2.08% | 1.51% | Upgrade |
Free Cash Flow Margin | 11.57% | 12.30% | -6.01% | -1.13% | 12.32% | -1.83% | Upgrade |
EBITDA | 1,059 | 747 | 332 | -50 | 391 | 896 | Upgrade |
EBITDA Margin | 8.71% | 6.19% | 2.69% | -0.41% | 3.03% | 6.26% | Upgrade |
D&A For EBITDA | 179 | 158 | 519 | 559 | 708 | 669 | Upgrade |
EBIT | 880 | 589 | -187 | -609 | -317 | 227 | Upgrade |
EBIT Margin | 7.24% | 4.88% | -1.52% | -5.06% | -2.46% | 1.59% | Upgrade |
Effective Tax Rate | 12.39% | 9.29% | - | - | - | 23.67% | Upgrade |
Advertising Expenses | - | 2,629 | 3,027 | 3,104 | 3,323 | 3,992 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.